Rosalba Carrozzo

Dr. Rosalba Carrozzo

Ospedale Pediatrico Bambino Gesù
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1998 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
VTValeria Tiranti
Valeria Tiranti
KHKonstanze Hoertnagel
Konstanze Hoertnagel
RCRosalba Carrozzo
Rosalba Carrozzo
CGClaudia Galimberti
Claudia Galimberti
MMMonica Munaro
Monica Munaro
Massimo ZevianiMassimo Zeviani
Massimo Zeviani

1 November 2001 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
FPFiorella Piemonte
Fiorella Piemonte
PAPastore Anna
Pastore Anna
GTGIULIA TOZZI
GIULIA TOZZI
DTD. Tagliacozzi
D. Tagliacozzi
FSF. M. Santorelli
F. M. Santorelli
EBEnrico Bertini
Enrico Bertini

1 September 2006 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
IWIlka Wittig
Ilka Wittig
RCRosalba Carrozzo
Rosalba Carrozzo
FSFilippo M. Santorelli
Filippo M. Santorelli
HSHermann Schägger
Hermann Schägger

14 February 2007 in Brain
Verified
Journal Article
Open access
PDF file
RCRosalba Carrozzo
Rosalba Carrozzo
CDCarlo Dionisi-Vici
Carlo Dionisi-Vici
USUlrike Steuerwald
Ulrike Steuerwald
SLSimona lucioli
Simona lucioli
FDFederica Deodato
Federica Deodato
RWRon Wevers
Ron Wevers
One pedigree with four patients has been recently described with mitochondrial DNA depletion and mutation in SUCLA2 gene leading to succinyl-CoA synthase deficiency. Patients had a Leigh-like encephalomyopathy and deafness but besides the presence of lactic acidosis, the profile of urine organic acid was not reported. We have studied 14 patients with mild ‘unlabelled’ methylmalonic aciduria (MMA) from 11 families. Eight of the families are from the Faroe Islands, having a common ancestor, and three are from southern Italy. Since the reaction catalysed by succinyl-CoA synthase in the tricarboxylic acid (TCA) cycle represents a distal step of the methylmalonic acid pathway, we investigated the SUCLA2 gene as a candidate gene in our patients. Genetic analysis of the gene in the 14 patients confirmed the defect in all patients and led to the identification of three novel mutations (p.Gly118Arg; p.Arg284Cys; c.534 + 1G → A). The defect could be convincingly shown at the protein level and our data also confirm the previously described mitochondrial DNA depletion. Defects in SUCLA2 can be found at the metabolite level and are defined by mildly elevated methylmalonic acid and C4-dicarboxylic carnitine concentrations in body fluids in association with variable lactic acidosis. Clinically the diagnosis should be considered in patients with early/neonatal onset encephalomyopathy, dystonia, deafness and Leigh-like MRI abnormalities mainly affecting the putamen and the caudate nuclei. The frequency of the mutated allele in the Faroese population amounted to 2%, corresponding with an estimated homozygote frequency of 1 : 2500. Our data extend knowledge on the genetic defects causing MMA. Our patients present with an early infantile Leigh-like encephalomyopathy with deafness, and later on a progressive dystonia. Mild MMA, lactic acidosis and specific abnormalities in the carnitine ester profile are the biochemical hallmarks of the disease. In view of the frequency of the mutated allele on the Faroe Islands, measures become feasible to prevent the occurrence of the disease on the islands. We confirm and extend the findings on this inborn error of metabolism in the TCA cycle that must be carefully investigated by accurate metabolite analyses.

1 December 2014 in The American Journal of Human Genetics
Verified
Journal Article
Open access
RKRobert Kopajtich
Robert Kopajtich
TNThomas Nicholls
Thomas Nicholls
JRJoanna Rorbach
Joanna Rorbach
MMMetodi D. Metodiev
Metodi D. Metodiev
PFPeter Freisinger
Peter Freisinger
PHProkisch Holger
Prokisch Holger
Respiratory chain deficiencies exhibit a wide variety of clinical phenotypes resulting from defective mitochondrial energy production through oxidative phosphorylation. These defects can be caused by either mutations in the mtDNA or mutations in nuclear genes coding for mitochondrial proteins. The underlying pathomechanisms can affect numerous pathways involved in mitochondrial physiology. By whole-exome and candidate gene sequencing, we identified 11 individuals from 9 families carrying compound heterozygous or homozygous mutations in GTPBP3, encoding the mitochondrial GTP-binding protein 3. Affected individuals from eight out of nine families presented with combined respiratory chain complex deficiencies in skeletal muscle. Mutations in GTPBP3 are associated with a severe mitochondrial translation defect, consistent with the predicted function of the protein in catalyzing the formation of 5-taurinomethyluridine (τm(5)U) in the anticodon wobble position of five mitochondrial tRNAs. All case subjects presented with lactic acidosis and nine developed hypertrophic cardiomyopathy. In contrast to individuals with mutations in MTO1, the protein product of which is predicted to participate in the generation of the same modification, most individuals with GTPBP3 mutations developed neurological symptoms and MRI involvement of thalamus, putamen, and brainstem resembling Leigh syndrome. Our study of a mitochondrial translation disorder points toward the importance of posttranscriptional modification of mitochondrial tRNAs for proper mitochondrial function.

21 May 2010 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CQCatarina M. Quinzii
Catarina M. Quinzii
Luis LopezLuis Lopez
Luis Lopez
RGRobert W. Gilkerson
Robert W. Gilkerson
BDBeatriz Dorado
Beatriz Dorado
JCJorida Coku
Jorida Coku
MHMichio Hirano
Michio Hirano
Coenzyme Q 10 (CoQ 10 ) is essential for electron transport in the mitochondrial respiratory chain and antioxidant defense. The relative importance of respiratory chain defects, ROS production, and apoptosis in the pathogenesis of CoQ 10 deficiency is unknown. We determined previously that severe CoQ 10 deficiency in cultured skin fibroblasts harboring COQ2 and PDSS2 mutations produces divergent alterations of bioenergetics and oxidative stress. Here, to better understand the pathogenesis of CoQ 10 deficiency, we have characterized the effects of varying severities of CoQ 10 deficiency on ROS production and mitochondrial bioenergetics in cells harboring genetic defects of CoQ 10 biosynthesis. Levels of CoQ 10 seem to correlate with ROS production;10‐15% and >60% residual CoQ 10 are not associated with significant ROS production, whereas 30‐50% residual CoQ 10 is accompanied by increased ROS production and cell death. Our results confirm that varying degrees of CoQ 10 deficiency cause variable defects of ATP synthesis and oxidative stress. These findings may lead to more rational therapeutic strategies for CoQ 10 deficiency.— Quinzii, C. M., Lopez, L. C., Gilkerson, R. W., Dorado, B., Coku, J., Naini, A. B., Lagier‐Tourenne, C., Schuelke, M., Salviati, L., Carrozzo, R., Santorelli, F., Rahman, S., Tazir, M., Koenig, M., DiMauro, S., Hirano, M. Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ 10 deficiency. FASEB J. 24, 3733–3743 (2010). www.fasebj.org